Article Cited by others


A sting in the tail: the N-terminal domain of the androgen receptor as a drug target

Monaghan Amy E, McEwan Iain J

Year : 2016| Volume: 18| Issue : 5 | Page no: 687-694

   This article has been cited by
1 Identification of ELK1 interacting peptide segments in the androgen receptor
Claire Soave, Charles Ducker, Seongho Kim, Thomas Strahl, Rayna Rosati, Yanfang Huang, Peter E. Shaw, Manohar Ratnam
Biochemical Journal. 2022; 479(14): 1519
[Pubmed]  [Google Scholar] [DOI]
2 (+)-JJ-74–138 is a Novel Noncompetitive Androgen Receptor Antagonist
Ryan N. Cole, Wei Chen, Laura E. Pascal, Joel B. Nelson, Peter Wipf, Zhou Wang
Molecular Cancer Therapeutics. 2022; 21(4): 483
[Pubmed]  [Google Scholar] [DOI]
3 N/C Interactions Are Dispensable for Normal In Vivo Functioning of the Androgen Receptor in Male Mice
Sarah El Kharraz, Vanessa Dubois, Kaisa-Mari Launonen, Laura Helminen, Jorma J Palvimo, Claude Libert, Elien Smeets, Lisa Moris, Roy Eerlings, Dirk Vanderschueren, Christine Helsen, Frank Claessens
Endocrinology. 2022; 163(9)
[Pubmed]  [Google Scholar] [DOI]
4 Development of a High-Throughput Screening Assay for Small-Molecule Inhibitors of Androgen Receptor Splice Variants
Amy E. Monaghan, Alison Porter, Irene. Hunter, Angus Morrison, Stuart P. McElroy, Iain J. McEwan
ASSAY and Drug Development Technologies. 2022;
[Pubmed]  [Google Scholar] [DOI]
5 Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer
Fuqiang Ban,Eric Leblanc,Ayse Derya Cavga,Chia-Chi Flora Huang,Mark R. Flory,Fan Zhang,Matthew E. K. Chang,Hélène Morin,Nada Lallous,Kriti Singh,Martin E. Gleave,Hisham Mohammed,Paul S. Rennie,Nathan A. Lack,Artem Cherkasov
Cancers. 2021; 13(14): 3488
[Pubmed]  [Google Scholar] [DOI]
6 hsa_circ_0001275 Is One of a Number of circRNAs Dysregulated in Enzalutamide Resistant Prostate Cancer and Confers Enzalutamide Resistance In Vitro
Marvin C. J. Lim, Anne-Marie Baird, John Greene, Ciara McNevin, Karine Ronan, Petar Podlesniy, Orla Sheils, Steven G. Gray, Ray S. McDermott, Stephen P. Finn
Cancers. 2021; 13(24): 6383
[Pubmed]  [Google Scholar] [DOI]
7 Advances in the computational development of androgen receptor antagonists
Xueping Hu,Xin Chai,Xuwen Wang,Mojie Duan,Jinping Pang,Weitao Fu,Dan Li,Tingjun Hou
Drug Discovery Today. 2020;
[Pubmed]  [Google Scholar] [DOI]
8 Therapeutic targeting of the androgen receptor (AR) and AR Variants in prostate cancer
Ramesh Narayanan
Asian Journal of Urology. 2020;
[Pubmed]  [Google Scholar] [DOI]
9 Ordered structure-forming properties of the intrinsically disordered AB region of hRXR? and its ability to promote liquid-liquid phase separation
Katarzyna Soltys,Andrzej Ozyhar
The Journal of Steroid Biochemistry and Molecular Biology. 2019; : 105571
[Pubmed]  [Google Scholar] [DOI]
10 Revealing metabolic liabilities of ralaniten to enhance novel androgen receptor targeted therapies
Jon K Obst,Jun Wang,Kunzhong Jian,David E. Williams,Amy H Tien,Nasrin Mawji,Teresa Tam,Yu Chi Yang,Raymond J. Andersen,Kim N. Chi,Bruce Montgomery,Marianne D. Sadar
ACS Pharmacology & Translational Science. 2019;
[Pubmed]  [Google Scholar] [DOI]
11 Intrinsic Disorder in Nuclear Receptor Amino Termini: From Investigational Challenge to Therapeutic Opportunity
Rambon Shamilov,Brian J. Aneskievich
Nuclear Receptor Research. 2019; 6
[Pubmed]  [Google Scholar] [DOI]
12 Mechanisms and Approaches for Overcoming Enzalutamide Resistance in Prostate Cancer
Alexandra Vander Ark,Jingchen Cao,Xiaohong Li
Frontiers in Oncology. 2018; 8
[Pubmed]  [Google Scholar] [DOI]
13 Androgen receptor and soy isoflavones in prostate cancer (Review)
Monika Sivonov?,Peter Kapl?n,Zuzana Tatarkov?,Lucia Lichardusov?,R?bert Dušenka,Jana Jurecekov?
Molecular and Clinical Oncology. 2018;
[Pubmed]  [Google Scholar] [DOI]
14 The potential of AR-V7 as a therapeutic target
Takuma Uo,Stephen R. Plymate,Cynthia C. Sprenger
Expert Opinion on Therapeutic Targets. 2018; 22(3): 201
[Pubmed]  [Google Scholar] [DOI]
15 A magic drug target: Androgen receptor
Dan Li,Wenfang Zhou,Jinping Pang,Qin Tang,Bingling Zhong,Chao Shen,Li Xiao,Tingjun Hou
Medicinal Research Reviews. 2018;
[Pubmed]  [Google Scholar] [DOI]
16 How order and disorder within paramyxoviral nucleoproteins and phosphoproteins orchestrate the molecular interplay of transcription and replication
Sonia Longhi,Louis-Marie Bloyet,Stefano Gianni,Denis Gerlier
Cellular and Molecular Life Sciences. 2017;
[Pubmed]  [Google Scholar] [DOI]
17 Androgen and estrogen sensitivity of bird song: a comparative view on gene regulatory levels
Carolina Frankl-Vilches,Manfred Gahr
Journal of Comparative Physiology A. 2017;
[Pubmed]  [Google Scholar] [DOI]
18 Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer
Suriyan Ponnusamy,Christopher C. Coss,Thirumagal Thiyagarajan,Kate Watts,Dong-Jin Hwang,Yali He,Luke A. Selth,Iain J. McEwan,Charles B. Duke,Jayaprakash Pagadala,Geetika Singh,Robert W. Wake,Christopher Ledbetter,Wayne D. Tilley,Tudor Moldoveanu,James T. Dalton,Duane D. Miller,Ramesh Narayanan
Cancer Research. 2017; 77(22): 6282
[Pubmed]  [Google Scholar] [DOI]
19 Nickel impact on human health: An intrinsic disorder perspective
Barbara Zambelli,Vladimir N. Uversky,Stefano Ciurli
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2016; 1864(12): 1714
[Pubmed]  [Google Scholar] [DOI]
20 Intrinsically disordered proteins and prostate cancer: pouring new wine in an old bottle
Prakash Kulkarni
Asian Journal of Andrology. 2016; 18(5): 659
[Pubmed]  [Google Scholar] [DOI]


Read this article